RxSight, Inc. (RXST)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019
Cash & Equivalents	12.6	25.17	14.46	8.83
Short-Term Investments	93.97	134.97	54.98	72.71
Cash & Cash Equivalents	106.56	160.14	69.44	81.54
Cash Growth	-33.46%	130.63%	-14.84%	-
Receivables	10.96	4.86	2.87	0.79
Inventory	14.84	8.03	8.29	7.22
Other Current Assets	2.2	3.26	0.91	0.65
Total Current Assets	134.56	176.3	81.5	90.2
Property, Plant & Equipment	14.08	15.5	18.61	19.25
Other Long-Term Assets	1.53	0.93	0.57	0.98
Total Long-Term Assets	15.61	16.43	19.18	20.23
Total Assets	150.16	192.72	100.68	110.43
Accounts Payable	2.6	1.69	1.13	2.2
Current Debt	1.97	1.53	1.27	0.99
Other Current Liabilities	12.67	7.86	9.19	5.27
Total Current Liabilities	17.24	11.08	11.6	8.46
Long-Term Debt	43.03	43.4	29.48	4.53
Other Long-Term Liabilities	0	0	3.83	74.48
Total Long-Term Liabilities	43.03	43.4	33.31	79.01
Total Liabilities	60.26	54.48	44.91	87.46
Total Debt	45	44.93	30.75	5.52
Debt Growth	0.14%	46.11%	457.51%	-
Common Stock	636.03	617.54	0	0
Retained Earnings	-546.03	-479.28	-430.59	-419.86
Comprehensive Income	-0.1	-0.02	-0	0.05
Shareholders' Equity	89.9	138.24	-430.59	-419.81
Total Liabilities and Equity	150.16	192.72	-385.69	-332.35
Net Cash / Debt	61.57	115.21	38.68	76.02
Net Cash / Debt Growth	-46.56%	197.83%	-49.12%	-
Net Cash Per Share	2.23	8.46	6.99	-
Working Capital	117.32	165.22	69.9	81.74
Book Value Per Share	3.25	10.15	-116.15	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).